drugset / Trial / NCT00201630

Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy

NCT00201630

Phase 3 Unknown 150 enrolled New York Prostate Institute Sanofi · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is better or not than starting it on the day of surgery.

Timeline

Start
2005-09
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule

Indications